Published online before print January 22, 2010
Article |
,
,
,
@
*Department of Immunopathology, Children, Youth and Women’s Health Service, North Adelaide, South Australia;
Discipline of Paediatrics, Faculty of Health Sciences, University of Adelaide, South Australia; and
Sansom Institute, University of South Australia, Adelaide, South Australia, Australia
@ To whom correspondence should be addressed. E-mail: antonio.ferrante{at}adelaide.edu.au.
The role of JNK in neutrophil chemotaxis and killing of microbial pathogens remains unclear. Using a recently described cell-permeable peptide inhibitor of the JNK pathway, based on the JBD of JIP-1, coupled to the protein transduction domain of HIV-TAT (TAT-JIP), in association with control peptides, we demonstrate that the JNK pathway plays a major role in regulating human neutrophil chemotaxis and killing of microbial pathogens. Serum-opsonized Staphylococcus aureus elicited JNK activation and c-jun phosphorylation. The activation of the JNK pathway and bactericidal activity were inhibited by the TAT-JIP peptide. The stimulation of oxygen radical generation by S. aureus was dependent on the JNK signaling pathway, as was the phagocytosis of serum-opsonized bacteria. Chemotaxis to activated serum complement but not random migration was inhibited by the TAT-JIP peptide. The findings demonstrate a major role for the JNK signaling pathway in neutrophil-mediated defense against microbial pathogens.
Key Words: JNK TAT-JIP peptide superoxide production phagocytosis adherence mechanism of bactericidal activity